Saurabh Saha
Chief Executive Officer at CENTESSA PHARMACEUTICALS PLC
Net worth: 4 M $ as of 30/05/2024
Profile
Saurabh Saha is the founder of BioMed Valley Discoveries, Inc. (founded in 2008) where he held the title of Chief Scientific Officer.
He is currently the Chief Executive Officer & Director at Centessa Pharmaceuticals Plc, Chief Executive Officer at Centessa Pharmaceuticals LLC, Director at Capella Bioscience Ltd., Director at Z Factor Ltd., Director at ApcinteX Ltd., Independent Director at Clarivate Plc (starting in 2023), Director at Scorpion Therapeutics, Inc. (starting in 2022), and Associate Member at Harvard Medical School.
Dr. Saha previously served as President, Chief Executive Officer & Director at Delinea, Inc. (United States) from 2016 to 2017, Director & Head-New Indications Discovery Unit at Novartis, Inc., Senior Vice President-Research & Development at Bristol Myers Squibb Co. from 2017 to 2021, and Chief Medical Officer at Synlogic Operating Co., Inc. Dr. Saha obtained a graduate degree from the University of Oxford, an undergraduate degree from the California Institute of Technology, and a doctorate degree from The Johns Hopkins University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/04/2024 | 378,437 ( 0.42% ) | 3 M $ | 30/05/2024 | |
CLARIVATE PLC
0.01% | 06/05/2024 | 41,387 ( 0.01% ) | 235 906 $ | 30/05/2024 |
Saurabh Saha active positions
| Companies | Position | Start |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Chief Executive Officer | 31/12/2020 |
| CLARIVATE PLC | Director/Board Member | 03/05/2023 |
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Director/Board Member | 28/01/2021 |
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Director/Board Member | 28/01/2021 |
Capella Bioscience Ltd.
 Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Capella Bioscience Ltd. develops medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease. The company was founded by Steve Holmes in 2014 and is headquartered in London, the United Kingdom. | Director/Board Member | 28/01/2021 |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Director/Board Member | 03/04/2022 |
| Harvard Medical School | Corporate Officer/Principal | - |
Centessa Pharmaceuticals, Inc.
 Centessa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Centessa Pharmaceuticals Plc, Centessa Pharmaceuticals LLC is a company that manufactures medicines. The company is based in Horsham, PA. The CEO of the company is Saurabh Saha. | Chief Executive Officer | - |
Former positions of Saurabh Saha
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/12/2020 |
| ░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
Training of Saurabh Saha
| California Institute of Technology | Undergraduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
| University of Oxford | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| CLARIVATE PLC | Commercial Services |
| Private companies | 9 |
|---|---|
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Delinea, Inc. (United States)
 Delinea, Inc. (United States) BiotechnologyHealth Technology Delinia, Inc. operates as a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases. Its main program is a molecule that potentiates and expands Regulatory T Cells, powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the path physiology of cancer and autoimmune disease. Delinia was founded by Michael Rosenblum and Jeffrey Greve in 2015 and is headquartered in Summit, NJ. | Health Technology |
ApcinteX Ltd.
ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Health Technology |
BioMed Valley Discoveries, Inc.
 BioMed Valley Discoveries, Inc. Miscellaneous Commercial ServicesCommercial Services BioMed Valley Discoveries, Inc. is a biotechnology company that develops therapies for cancer, inflammation, and infectious disease. The private company is based in Kansas City, MO. The company was founded by Saurabh Saha. | Commercial Services |
Z Factor Ltd.
Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Health Technology |
Capella Bioscience Ltd.
Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Capella Bioscience Ltd. develops medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease. The company was founded by Steve Holmes in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Health Technology |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
Centessa Pharmaceuticals, Inc.
Centessa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Centessa Pharmaceuticals Plc, Centessa Pharmaceuticals LLC is a company that manufactures medicines. The company is based in Horsham, PA. The CEO of the company is Saurabh Saha. | Health Technology |
- Stock Market
- Insiders
- Saurabh Saha
